Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients ...

LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...

Written FDA recommendations include a second Phase 3 trial to generate additional efficacy and safety data prior to NDA ...

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...

In this article, we will discuss the 9 Best QQQ Stocks to Buy Now. On April 8, Yung-Yu Ma of PNC joined ‘Fast Money’ on CNBC to discuss the current market environment and noted that worst-case ...

Investigating omega-3 fatty acids, this review highlights their impact on mental health, inflammation, and the potential for therapeutic use in disorders.

Nike beat Q3 estimates with $0.35 EPS and $11.28B revenue, but shares fell 7.3% to $47.50 in premarket as investors focused ...

LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately 460 patients Primary endpoint to evaluate change in PANSS total score at week ...

Toyota has recalled more than 13,000 HiLux utes across Australia over a steering fault linked not to the vehicle itself, but ...

Neurocrine Biosciences is in advanced talks to acquire Soleno Therapeutics for just over $2.5 billion, or low-to-mid $50s per ...

LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately 460 patients. Primary endpoint to evaluate change in PAN ...